Rare lephants
Screener

Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Nov 10, 2020 8-K
8-K Oct 30, 2020 8-K
S-8 Oct 2, 2020 FORM S-8
4 Oct 1, 2020
4 Sep 30, 2020 PRIMARY DOCUMENT
4 Sep 30, 2020 PRIMARY DOCUMENT
4 Sep 30, 2020 PRIMARY DOCUMENT
4 Sep 30, 2020 PRIMARY DOCUMENT
4 Sep 30, 2020 PRIMARY DOCUMENT
4 Sep 30, 2020 PRIMARY DOCUMENT
4 Sep 30, 2020 PRIMARY DOCUMENT
4 Sep 30, 2020 PRIMARY DOCUMENT
8-K/A Sep 29, 2020 8-K/A
8-K Sep 29, 2020 8-K
EFFECT Sep 1, 2020
CORRESP Aug 31, 2020
UPLOAD Aug 24, 2020
DEFA14A Aug 19, 2020 DEFA14A
DEF 14A Aug 19, 2020 DEF 14A
S-3 Aug 14, 2020 S-3
8-K/A Aug 14, 2020 8-K/A
10-Q Aug 14, 2020 10-Q
8-K Aug 11, 2020 FORM 8-K
8-K Aug 6, 2020 FORM 8-K
EFFECT Jul 14, 2020
← Newer Page 12 of 28 · 696 filings Older →